ReviewCurrent oncology reports2021

Upfront Management of ALK-Rearranged Metastatic Non-small Cell Lung Cancer: One Inhibitor Fits All?

Fabrizio Tabbò et al.PubMed ↗Publisher ↗

No numbers read from the abstract.